Education

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Page 8 of 8

Results 526 - 556 of 556

Specialty Area

Are You Ready to Use Biosimilars in Your Practice?

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Radiologic Features of IPF

Gwen: A lawyer with a history of MI has a dry cough and trouble with stairs

Elizabeth: Loves the outdoors but bothered by persistent cough and GERD

Toni: Too tired to continue teaching and experiencing painful heartburn

Individualizing Patient Education in Treatment Choice: Practical Strategies

A 30 y/o Female w/2-year History of Shoulder Weakness and Elevated AST and ALT

32 y/o Male w/Progressive Weakness, Dilated Cardiomyopathy & Respiratory...

A 60 y/o Male w/4-year History Of Shoulder Weakness

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Individualizing Patient Education in Treatment Choice: Practical Strategies

Addressing Common Barriers to Adherence

Approach to Genetic Testing in Myopathies

Molecular Diagnosis of Limb-Girdle Muscle Weakness

Discovering New Drugs for IPF

Biomarkers for IPF

New Trends in IPF

New Trends in IPF

Treatment Dilemmas Case Study: Harrison

A New Era in IPF: Trials and Treatments

Highlights from ATS 2014: Discussions on Clinical Trial Data

Highlights from ATS 2014: Update on Predicting Clinical Progression

Highlights from ATS 2014: Top Line Clinical Trial Results - ASCEND, INPULSIS, and PANTHER

Exciting IPF Developments from 2015 ERS

Exciting Developments from 2015 CHEST

Page 8 of 8